BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33785838)

  • 21. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Mycobacterium tuberculosis leucyl-tRNA synthetase (LeuRS) inhibitors among the derivatives of 5-phenylamino-2H-[1,2,4]triazin-3-one.
    Gudzera OI; Golub AG; Bdzhola VG; Volynets GP; Kovalenko OP; Boyarshin KS; Yaremchuk AD; Protopopov MV; Yarmoluk SM; Tukalo MA
    J Enzyme Inhib Med Chem; 2016; 31(sup2):201-207. PubMed ID: 27241561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells.
    Alumasa JN; Manzanillo PS; Peterson ND; Lundrigan T; Baughn AD; Cox JS; Keiler KC
    ACS Infect Dis; 2017 Sep; 3(9):634-644. PubMed ID: 28762275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
    Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
    Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
    Sharma K; Tanwar O; Deora GS; Ali S; Alam MM; Zaman MS; Krishna VS; Sriram D; Akhter M
    Bioorg Med Chem; 2019 Apr; 27(7):1421-1429. PubMed ID: 30827867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
    Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
    Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Characterization of Chemical Compounds that Inhibit Leucyl-tRNA Synthetase from
    Zamacona R; Chavero PN; Medellin E; Hu Y; Hughes CA; Quach N; Keniry M; Bullard JM
    Curr Drug Discov Technol; 2020; 17(1):119-130. PubMed ID: 30088448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
    Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure-antituberculosis activity relationships study in a series of 5-aryl-2-thio-1,3,4-oxadiazole derivatives.
    Macaev F; Ribkovskaia Z; Pogrebnoi S; Boldescu V; Rusu G; Shvets N; Dimoglo A; Geronikaki A; Reynolds R
    Bioorg Med Chem; 2011 Nov; 19(22):6792-807. PubMed ID: 22001325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design.
    Kazakova O; Racoviceanu R; Petrova A; Mioc M; Militaru A; Udrescu L; Udrescu M; Voicu A; Cummings J; Robertson G; Ordway DJ; Slayden RA; Șoica C
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
    Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH
    Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel isoniazid derivative as promising antituberculosis agent.
    Volynets GP; Tukalo MA; Bdzhola VG; Derkach NM; Gumeniuk MI; Tarnavskiy SS; Yarmoluk SM
    Future Microbiol; 2020 Jul; 15(10):869-879. PubMed ID: 32662670
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
    Li X; Hernandez V; Rock FL; Choi W; Mak YSL; Mohan M; Mao W; Zhou Y; Easom EE; Plattner JJ; Zou W; Pérez-Herrán E; Giordano I; Mendoza-Losana A; Alemparte C; Rullas J; Angulo-Barturen I; Crouch S; Ortega F; Barros D; Alley MRK
    J Med Chem; 2017 Oct; 60(19):8011-8026. PubMed ID: 28953378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis and Antimicrobial Evaluation of New
    Šlechta P; Needle AA; Jand'ourek O; Paterová P; Konečná K; Bárta P; Kuneš J; Kubíček V; Doležal M; Kučerová-Chlupáčová M
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxadiazole scaffolds in anti-tuberculosis drug discovery.
    De SS; Khambete MP; Degani MS
    Bioorg Med Chem Lett; 2019 Aug; 29(16):1999-2007. PubMed ID: 31296357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.